Cardiovascular Toxicology & Pharmacology

Cardiovascular pharmacology deals with the treatment of heart disease. Cardiac medications are used to treat the cardiac, circulatory and vascular system. Various cardiovascular agents are available to treat various cardiovascular conditions. Sodium, potassium, calcium channel blockers, ACE inhibitors and cardiac biomarkers. Cardiovascular Toxicology is the field which essentially focuses to the antagonistic impacts on the heart or blood frameworks that outcome from presentation to lethal synthetic compounds. It expounds wellbeing information of unfavorable impacts of new cardiovascular meds. Pharmacology of vascular endothelium manages alterations of endothelial cells and the vasculature have a pivotal influence in the pathogenesis of a wide scope of the most appalling of human illnesses, as endothelial cells have the imperative job of taking an interest in the upkeep of patent and useful vessels.

  • Novel anti-inflammatory therapies for atherosclerosis
  • Drug-induced cardiac toxicity
  • Development of novel anti-ischemic agents
  • Biomarkers

Related Conference of Cardiovascular Toxicology & Pharmacology

April 24-25, 2024

33rd Neonatology and Primary Care Congress

Paris, France
April 30-30, 2024

14th International Conference on Womens Health and Cancer Cure

Amsterdam, Netherlands
July 25-26, 2024

20th World Summit on Blockchain Technology

Amsterdam, Netherlands
August 20-21, 2024

11th World Summit on Epilepsy and Bipolar Disorders

Montreal, Canada
September 26-27, 2024

7th Annual Congress on Emergency Medicine and Acute Care

Amsterdam, Netherlands
October 14-15, 2024

11th World Machine Learning and Deep learning Conference

Barcelona, Spain

Cardiovascular Toxicology & Pharmacology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in